Signal-transducing adaptor protein-2 controls the IgE-Mediated, mast cell-mediated anaphylactic responses

Yuichi Sekine, Keigo Nishida, Satoru Yamasaki, Ryuta Muromoto, Shigeyuki Kon, Jun Ichi Kashiwakura, Kodai Saitoh, Sumihito Togi, Akihiko Yoshimura, Kenji Oritani, Tadashi Matsuda

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Signal-transducing adaptor protein-2 (STAP-2) is a recently identified adaptor protein that regulates immune and inflammatory responses through interactions with a variety of signaling and transcriptional molecules. In the current study, we clarified the physiological role of STAP-2 in mast cell function, a key mediator of IgE-associated allergic responses. STAP-2 is constitutively expressed in mast cells. STAP-2 deficiency in mast cells greatly enhances FcRI-mediated signals, resulting in the increased tyrosine phosphorylation of the phospholipase C-g isoform, calcium mobilization, and degranulation. Of importance, STAP-2-deficient mice challenged with DNP-BSA after passive sensitization with anti-DNP IgE show more severe rectal temperature decrease than do wild-type mice. STAP-2-deficient mice also show increased vascular permeability and more severe cutaneous anaphylaxis after DNP-BSA injection. These regulatory functions performed by STAP-2 indicate that there is an interaction between STAP-2 and FcRI. In addition, our previous data indicate that STAP-2 binds to the phospholipase C-g isoform and IkB kinase-b. Therefore, our data described in this article strongly suggest that manipulation of STAP-2 expression in mast cells may control the pathogenesis of allergic diseases and have the potential for treating patients with allergy.

Original languageEnglish
Pages (from-to)3488-3495
Number of pages8
JournalJournal of Immunology
Volume192
Issue number8
DOIs
Publication statusPublished - 2014 Apr 15

Fingerprint

Signal Transducing Adaptor Proteins
Mast Cells
Immunoglobulin E
Type C Phospholipases
Protein Isoforms
Protein Deficiency
Capillary Permeability
Anaphylaxis

ASJC Scopus subject areas

  • Immunology

Cite this

Sekine, Y., Nishida, K., Yamasaki, S., Muromoto, R., Kon, S., Kashiwakura, J. I., ... Matsuda, T. (2014). Signal-transducing adaptor protein-2 controls the IgE-Mediated, mast cell-mediated anaphylactic responses. Journal of Immunology, 192(8), 3488-3495. https://doi.org/10.4049/jimmunol.1300886

Signal-transducing adaptor protein-2 controls the IgE-Mediated, mast cell-mediated anaphylactic responses. / Sekine, Yuichi; Nishida, Keigo; Yamasaki, Satoru; Muromoto, Ryuta; Kon, Shigeyuki; Kashiwakura, Jun Ichi; Saitoh, Kodai; Togi, Sumihito; Yoshimura, Akihiko; Oritani, Kenji; Matsuda, Tadashi.

In: Journal of Immunology, Vol. 192, No. 8, 15.04.2014, p. 3488-3495.

Research output: Contribution to journalArticle

Sekine, Y, Nishida, K, Yamasaki, S, Muromoto, R, Kon, S, Kashiwakura, JI, Saitoh, K, Togi, S, Yoshimura, A, Oritani, K & Matsuda, T 2014, 'Signal-transducing adaptor protein-2 controls the IgE-Mediated, mast cell-mediated anaphylactic responses', Journal of Immunology, vol. 192, no. 8, pp. 3488-3495. https://doi.org/10.4049/jimmunol.1300886
Sekine, Yuichi ; Nishida, Keigo ; Yamasaki, Satoru ; Muromoto, Ryuta ; Kon, Shigeyuki ; Kashiwakura, Jun Ichi ; Saitoh, Kodai ; Togi, Sumihito ; Yoshimura, Akihiko ; Oritani, Kenji ; Matsuda, Tadashi. / Signal-transducing adaptor protein-2 controls the IgE-Mediated, mast cell-mediated anaphylactic responses. In: Journal of Immunology. 2014 ; Vol. 192, No. 8. pp. 3488-3495.
@article{90ff433f0c734b498956456ae4d240ab,
title = "Signal-transducing adaptor protein-2 controls the IgE-Mediated, mast cell-mediated anaphylactic responses",
abstract = "Signal-transducing adaptor protein-2 (STAP-2) is a recently identified adaptor protein that regulates immune and inflammatory responses through interactions with a variety of signaling and transcriptional molecules. In the current study, we clarified the physiological role of STAP-2 in mast cell function, a key mediator of IgE-associated allergic responses. STAP-2 is constitutively expressed in mast cells. STAP-2 deficiency in mast cells greatly enhances FcRI-mediated signals, resulting in the increased tyrosine phosphorylation of the phospholipase C-g isoform, calcium mobilization, and degranulation. Of importance, STAP-2-deficient mice challenged with DNP-BSA after passive sensitization with anti-DNP IgE show more severe rectal temperature decrease than do wild-type mice. STAP-2-deficient mice also show increased vascular permeability and more severe cutaneous anaphylaxis after DNP-BSA injection. These regulatory functions performed by STAP-2 indicate that there is an interaction between STAP-2 and FcRI. In addition, our previous data indicate that STAP-2 binds to the phospholipase C-g isoform and IkB kinase-b. Therefore, our data described in this article strongly suggest that manipulation of STAP-2 expression in mast cells may control the pathogenesis of allergic diseases and have the potential for treating patients with allergy.",
author = "Yuichi Sekine and Keigo Nishida and Satoru Yamasaki and Ryuta Muromoto and Shigeyuki Kon and Kashiwakura, {Jun Ichi} and Kodai Saitoh and Sumihito Togi and Akihiko Yoshimura and Kenji Oritani and Tadashi Matsuda",
year = "2014",
month = "4",
day = "15",
doi = "10.4049/jimmunol.1300886",
language = "English",
volume = "192",
pages = "3488--3495",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "8",

}

TY - JOUR

T1 - Signal-transducing adaptor protein-2 controls the IgE-Mediated, mast cell-mediated anaphylactic responses

AU - Sekine, Yuichi

AU - Nishida, Keigo

AU - Yamasaki, Satoru

AU - Muromoto, Ryuta

AU - Kon, Shigeyuki

AU - Kashiwakura, Jun Ichi

AU - Saitoh, Kodai

AU - Togi, Sumihito

AU - Yoshimura, Akihiko

AU - Oritani, Kenji

AU - Matsuda, Tadashi

PY - 2014/4/15

Y1 - 2014/4/15

N2 - Signal-transducing adaptor protein-2 (STAP-2) is a recently identified adaptor protein that regulates immune and inflammatory responses through interactions with a variety of signaling and transcriptional molecules. In the current study, we clarified the physiological role of STAP-2 in mast cell function, a key mediator of IgE-associated allergic responses. STAP-2 is constitutively expressed in mast cells. STAP-2 deficiency in mast cells greatly enhances FcRI-mediated signals, resulting in the increased tyrosine phosphorylation of the phospholipase C-g isoform, calcium mobilization, and degranulation. Of importance, STAP-2-deficient mice challenged with DNP-BSA after passive sensitization with anti-DNP IgE show more severe rectal temperature decrease than do wild-type mice. STAP-2-deficient mice also show increased vascular permeability and more severe cutaneous anaphylaxis after DNP-BSA injection. These regulatory functions performed by STAP-2 indicate that there is an interaction between STAP-2 and FcRI. In addition, our previous data indicate that STAP-2 binds to the phospholipase C-g isoform and IkB kinase-b. Therefore, our data described in this article strongly suggest that manipulation of STAP-2 expression in mast cells may control the pathogenesis of allergic diseases and have the potential for treating patients with allergy.

AB - Signal-transducing adaptor protein-2 (STAP-2) is a recently identified adaptor protein that regulates immune and inflammatory responses through interactions with a variety of signaling and transcriptional molecules. In the current study, we clarified the physiological role of STAP-2 in mast cell function, a key mediator of IgE-associated allergic responses. STAP-2 is constitutively expressed in mast cells. STAP-2 deficiency in mast cells greatly enhances FcRI-mediated signals, resulting in the increased tyrosine phosphorylation of the phospholipase C-g isoform, calcium mobilization, and degranulation. Of importance, STAP-2-deficient mice challenged with DNP-BSA after passive sensitization with anti-DNP IgE show more severe rectal temperature decrease than do wild-type mice. STAP-2-deficient mice also show increased vascular permeability and more severe cutaneous anaphylaxis after DNP-BSA injection. These regulatory functions performed by STAP-2 indicate that there is an interaction between STAP-2 and FcRI. In addition, our previous data indicate that STAP-2 binds to the phospholipase C-g isoform and IkB kinase-b. Therefore, our data described in this article strongly suggest that manipulation of STAP-2 expression in mast cells may control the pathogenesis of allergic diseases and have the potential for treating patients with allergy.

UR - http://www.scopus.com/inward/record.url?scp=84898670990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898670990&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1300886

DO - 10.4049/jimmunol.1300886

M3 - Article

C2 - 24616480

AN - SCOPUS:84898670990

VL - 192

SP - 3488

EP - 3495

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 8

ER -